A Critical Review of the Molecular and Clinical Effects of Cilostazol After Percutaneous Coronary Intervention
Roberto Ferrari, Pasquale Perrone Filardi

TL;DR
This paper reviews how cilostazol, a drug approved for leg pain, may help prevent artery re-narrowing after heart procedures, especially in high-risk patients.
Contribution
The paper provides a critical review of cilostazol's molecular and clinical effects in reducing restenosis after PCI, highlighting its underutilization.
Findings
Cilostazol inhibits smooth muscle proliferation and intimal hyperplasia in experimental models.
Clinical trials show cilostazol reduces restenosis compared to aspirin or clopidogrel after PCI.
Cilostazol is underused despite evidence supporting its effectiveness in preventing coronary restenosis.
Abstract
Background: Restenosis after coronary stent implantation remains a major clinical challenge, especially in patients with diabetes, long lesions, or multiple stents. Standard therapy with aspirin and P2Y12 inhibitors does not reliably prevent this complication. Objectives: We reviewed experimental and clinical evidence on cilostazol, a selective phosphodiesterase-3 inhibitor, as a strategy to reduce restenosis after percutaneous coronary intervention (PCI). Methods: Preclinical and clinical studies were critically appraised, focusing on the effects of cilostazol on vascular smooth muscle and endothelial cells, platelet aggregation, lipid metabolism, and restenosis rates. Results: Experimental models show that cilostazol inhibits smooth muscle proliferation and intimal hyperplasia after arterial injury. Clinical trials demonstrate reduced restenosis after balloon angioplasty and stent…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntiplatelet Therapy and Cardiovascular Diseases · Coronary Interventions and Diagnostics · Lipoproteins and Cardiovascular Health
